Please use this identifier to cite or link to this item:
|Title:||Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study.|
Aged, 80 and over
|Citation:||Epilepsy Res..2016 10;(126):201-10|
|Abstract:||Real-world data of current antiepileptic drugs (AEDs) used to treat focal seizures is of importance to understand the efficacy and safety outside of the clinical trial setting. Here we report real-world data from a large series of patients treated with perampanel for 1year.|
|Appears in Collections:||Hospitales > H. U. Infanta Sofía > Artículos|
Files in This Item:
The file with the full text of this item is not available due to copyright restrictions or because there is no digital version. Authors can contact the head of the repository of their center to incorporate the corresponding file.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.